You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

activating genetic alteration

Showing 1 - 25 of 9,179
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)

Not yet recruiting
  • Low-grade Glioma
  • (no location specified)
Oct 3, 2022

Cancer Trial in Chicago, Philadelphia, Memphis (Remote Telegenetic Counseling by Phone, Remote Telegenetic Counseling by

Recruiting
  • Cancer
  • Remote Telegenetic Counseling by Phone
  • +2 more
  • Chicago, Illinois
  • +2 more
Mar 10, 2022

Metastatic Melanoma Trial in San Francisco (Niraparib)

Recruiting
  • Metastatic Melanoma
  • San Francisco, California
    California Pacific Medical Center Research Institute
Oct 15, 2021

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Afatinib

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Afatinib Dimaleate
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 28, 2022

ATM Alterations by Next-Generation Sequencing and ATM

Completed
  • Solid Tumor, Unspecified, Adult
  • Determination of ATM alteration status.
  • Oklahoma City, Oklahoma
  • +2 more
Jul 29, 2022

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

Metastatic and/or High Risk Solid Tumor of Children Trial in Paris (Tumoral specific genetic alterations)

Unknown status
  • Metastatic and/or High Risk Solid Tumor of Children
  • Tumoral specific genetic alterations
  • Paris, France
    Institut Curie
Aug 6, 2020

Lung Cancer Trial in Busan (Ultrathin bronchoscopy with intratumoral washing)

Not yet recruiting
  • Lung Cancer
  • Ultrathin bronchoscopy with intratumoral washing
  • Busan, Korea, Republic of
    Pusan National University hospital
Nov 17, 2023

Extended Analysis for Leukemia/Lymphoma Treatment

Completed
  • Relapsed Hematologic Malignancy
  • ngFDS selected treatment
  • Vienna, Austria
    Medical University Vienna
Feb 22, 2021

EGFR Activating Mutation, Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Winston-Salem (drug, biological,

Terminated
  • EGFR Activating Mutation
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jan 28, 2021

Relapsed Refractory Multiple Myeloma Trial in United States (Abemaciclib, dexamethasone, ixazomib, pomalidomide, Enasidenib,

Recruiting
  • Relapsed Refractory Multiple Myeloma
  • Abemaciclib, dexamethasone, ixazomib, pomalidomide
  • +7 more
  • Phoenix, Arizona
  • +16 more
Sep 9, 2021

Melanoma Trial (Fluzoparib Camrelizumab Temozolomide)

Not yet recruiting
  • Melanoma
  • Fluzoparib Camrelizumab Temozolomide
  • (no location specified)
Aug 9, 2023

Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)

Recruiting
  • Solid Tumor
  • Haematological Malignancy
  • Belfast, United Kingdom
  • +24 more
Jan 31, 2023

Hematologic Cancers, Solid Tumors, Metastatic Cancer Trial in Villejuif (Crizotinib)

Active, not recruiting
  • Hematologic Cancers
  • +2 more
  • Villejuif, Ile De France, France
    Gustave Roussy
Sep 5, 2022

Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States

Recruiting
  • Malignant Solid Neoplasm
  • +40 more
  • Biospecimen Collection
  • +6 more
  • Birmingham, Alabama
  • +172 more
Jan 27, 2023

Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +108 more
Oct 19, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +37 more
  • Birmingham, Alabama
  • +171 more
Aug 24, 2022

Metastatic or Locally Advanced Malignancies Trial in Germany (Vemurafenib, Cobimetinib, Atezolizumab)

Recruiting
  • Metastatic or Locally Advanced Malignancies
  • Berlin, Germany
  • +5 more
Jan 2, 2023

IBD, Crohn Disease, Ulcerative Colitis Trial in Orléans (Blood and fecal samples, Coolonic biopsies)

Recruiting
  • Inflammatory Bowel Diseases
  • +2 more
  • Blood and fecal samples
  • Coolonic biopsies
  • Orléans, France
    CHR Orléans
Jun 14, 2023

Lung Cancer, NSCLC, Pulmonary Tumor Trial in Germany (ERDAFITINIB)

Unknown status
  • Lung Cancer
  • +4 more
  • Gauting, Bavaria, Germany
  • +10 more
Nov 11, 2020

A Taiwanese Oncogenetic Panel and Integrated Clinical Data

Recruiting
  • Thyroid Cancer
  • A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients
  • Kaohsiung, Taiwan
  • +7 more
Sep 12, 2022

Solid Tumors, Hematologic Cancers, Metastatic Cancers Trial in Paris (Vemurafenib)

Active, not recruiting
  • Solid Tumors
  • +2 more
  • Paris, France
    Tredaniel
May 18, 2022

Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +118 more
Jan 27, 2023

ALK-activated Tumors Trial in Worldwide (Ceritinib)

Completed
Has Results
  • ALK-activated Tumors
  • Boston, Massachusetts
  • +22 more
May 27, 2020

Biomarker Research in Inherited Movement Disorders

Recruiting
  • Inherited Movement Disorders
  • +2 more
  • Clinical follow-up
  • Paris, France
    Hôpital Pitié Salpetrière
Aug 11, 2022